RIGHT Foundation, Research Investment for Global Health Technology Foundation

🚨 The Annual RIGHT Foundation Forum is about to begin! Join us live on YouTube to be part of this year’s insightful discussions on global health R&D and equitable access to essential health technologies. Don’t miss it! 🔗 Watch here: https://lnkd.in/gUsvjYTq Stay tuned!

📢 On Tuesday, November 12, the Annual RIGHT Foundation Forum, hosted by RIGHT, will be held at Songdo Convensia. With the theme "Driving Global Health R&D with an End-to-End Approach Towards Equitable Access to Essential Health Technologies," the Forum will unite key stakeholders in global health—including governments, industries, funders, and R&D organizations—for in-depth discussions on advancing health equity worldwide. We look forward to connecting with you there!

My sincere congratulations to Developing Countries Vaccine Manufacturers Network (DCVMN International) for its 25th anniversary and to FIOCRUZ - Fundação Oswaldo Cruz and Fundação Butantan for hosting this year's forum superbly. The richness of the topics discussed, the diversity of the participants and the attendees and the masterful orchestrating by the hosts in the city of Sao Paulo made this 25th Anniversary forum truly memorable. That DCVM network has continued to flourish into its 25th year is an inspiring affirmation that through collective efforts, it is indeed possible to develop and make available vaccines as global public goods for health equity. RIGHT Foundation, Research Investment for Global Health Technology Foundation is honoured to have joined Session 3: Innovations in Financial Mechanisms: Influence & Impact on Universal Coverage". It is critically important that funders coordinate and collaborate to fill funding gaps throughout R&D, manufacturing, policy development and procurement to ensure that R&D results in equitable access to essential vaccines. No funder is big enough to do this alone. Only through collective efforts, we can support global health R&D from end to end, from R&D to equitable access. Rajinder Suri, Perla Villani Borges

The RIGHT Foundation has decided to support Rapigen Inc.'s malaria diagnostic kit project. Rapigen brings its expertise in black gold nanoparticle technology, which enhances the sensitivity of malaria mutation detection. RIGHT Foundation’s backing will help Rapigen further develop and distribute this technology. Clinical trials are planned in Ethiopia and Brazil, with the aim of achieving WHO PQ approval by 2027, positioning this innovation to play a critical role in global health efforts to combat malaria. Read more:

🌟 These significant speakers marked the end of BMK and VWEA 2024, sharing remarkable insights on the future of biologics manufacturing: 1. HoJin Lee, Head of Biologics Manufacturing Plant, Daewoong Bio Inc.: Navigating Challenges in Bioplant Construction: Lessons Learned and Solutions Explored 2. Hoon Sang Lee, Chief Strategy Officer, RIGHT Foundation, Research Investment for Global Health Technology Foundation: Driving R&D Towards Global Public Health and Health Equity: RIGHT Foundation's Approach for Global Health R&D and Local Biomanufacturing in LMICs 3. Justin Seung Ho Y., Chief Executive Officer & Founder, YOUTH BIO GLOBAL: Cell Culture Automation based on Advanced Protein Coating Technology Application Thank you to everyone who contributed to making today so impactful. Tomorrow promises even more exciting sessions! #BiologicsManufacturingKorea #VaccineWorldEastAsia #BMK2024 #VWEA2024

It was a great pleasure to meet with His Excellency Alejandro Peláez, the Ambassador of Colombia to South Korea, today. We had a fruitful discussion on developing new partnership opportunities for infectious disease specialists from both South Korea and Colombia. Hoon Sang Lee, Chief Strategy Officer (CSO) of the RIGHT Foundation, Research Investment for Global Health Technology Foundation, had the privilege of introducing our foundation's support for R&D in infectious diseases. His Excellency Alejandro Peláez shared Colombia's ambitious plans to accelerate the improvement of its domestic biomanufacturing capabilities.   RIGHT Foundation welcomes new opportunities to leverage Korea's advanced biotechnology to enhance global health equity, and Colombia is an emerging nation with great potential for collaboration with Korea. Today's meeting is a stepping stone for more collaborative work, and we are looking forward to new opportunities in the near future to advance our mutual goals.

Due to the unprecedented number of high-quality proposals received since the Production Development Award (PDA) General Call was released on 1 November 2023, the RIGHT Foundation is pleased to announce that the PDA General Call will close at 10:00 AM KST on 19 August 2024. If you plan to submit an application, please visit our website (https://lnkd.in/daK3rbbJ) for detailed information. The next call for proposals will be available early next year.

Congratulations to the 41 Awardees of RIGHT Foundation, Research Investment for Global Health Technology Foundation Training Award! They just arrived in Korea to complete a five-week hands-on training in vaccine manufacturing at K-NIBRT. The awardees represent 17 institutions from 13 low- and middle-income countries and have been selected based on their significant potential to amplify the training impact and contribute to their national and regional capabilities to manufacture essential vaccines for public health. Vaccine inequity is rooted in inequity in material resources and knowledge. RIGHT Foundation aspires to contribute to improving vaccine equity by sharing material resources and knowledge. The Training Award program is intended to support Korean Ministry of Health and Welfare (MOHW)'s initiative, the Global Training Hub for Biomanufacturing.   I am immensely proud of our first cohort of trainees and to be part of their learning journey. Gyoonhee Han, Shinki An, #VaccineTraining, #RIGHTFoundation, #KNIBRT

🙌 Biouplus Interphex 👉 Date: 10th-12th July, 2024 👉 Venue: COEX 🚨 BIOPLUS-INTERPHEX KOREA is a bio-pharmaceutical exhibition that encompasses biopharmaceutical Value Chain and proposes ways by providing keynote sessions, over 30 conferences, exhibition, partnering, open innovation and networking opportunities to expand overseas by building global business networks. #koreabio #bioplus #interphex

RIGHT Foundation, Research Investment for Global Health Technology Foundation was honored to co-host the roundtable on ‘Enhancing Diagnostic Access in Low- and Middle-income Countries: Mobilizing Korean Innovation and Collaboration’ with National Assembly Members Jiho Cha and Zeea Han and 국경없는의사회 (Médecins Sans Frontières, MSF Korea). The event was highlighted by the presence of distinguished guests from Ministry of Health and Welfare, Korea Disease Control and Prevention Agency, Ministry of Food and Drug Safety of Republic of Korea, Korea In Vitro Diagnostics Association (KIVDA), and a few other members of the National Assembly. Executive Director Hani Kim of the RIGHT Foundation delievered a presentation on Korea’s stength in R&D and regulatory capabilities for diagnostics. She emphasized Korea’s unique position to lead ‘international collaboration for health equity rooted in solidarity.’ In line with her emphasis on collaboration and innovation, the subsequent panel discussion, focused on the concerted endeavor of various branches of the Korean government to enhance global health equity, was enriched with industry accounts of global health from the RIGHT Foundation’s Industry Council members - #Bioneer, #Noul, and #SDBiosensor.